Page 326 - Syndipharma

Raha Pharmaceutical Co.

Type Product Dosage Strength Indication Status
form

General Internal Cetadin- D (160 mg+12.5 Analgesic/Decongestant/Anti-histamine/ In Market
mg+2.5 mg)/5ml
Anti-emetic
(125 mg+50 Analgesic/Decongestant/Anti-histamine/ IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
General Internal Cetadin- G mg+2.5 mg)/5ml Anti-emetic In Market
Syrup
General Internal Cetadin-DC (160 mg+1mg+5 Analgesic/Decongestant/Anti-histamine/ In Market
mg+2.5 mg)/5ml Anti-emetic

General Internal Lactulose 10mg/15ml - In Market

Neurology Rahakin 200 mg Anti convulsant In Market

Neurology Rahakin 500 mg Anti convulsant In Market

Neurology Tegatard 200 mg Anti convulsant In Market

Neurology Tegatard 400 mg Anti convulsant In Market

Analgesic Voldic 100 mg NSAID-Analgesic In Market
Tablet
General Internal Rahamet 500 mg Anti-diabetic In Market

General Internal Rahamet 1000 mg Anti-diabetic In Market

Supplement L-Arginine 1000 mg Supplement-Amino Acid In Market

Supplement B12 2500 mcg Supplement In Market

Supplement L- Lysine 500 mg Supplement-Amino Acid In Market

325